Bausch Health
BHC
#4243
Rank
โ‚น228.62 B
Marketcap
โ‚น616.32
Share price
-1.59%
Change (1 day)
-5.50%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น87.66. In 2024 the company made an earnings per share (EPS) of -โ‚น10.84 an increase over its 2023 EPS that were of -โ‚น146.40.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-881.07%
2024-โ‚น10.84-92.59%
2023-โ‚น146.40160.89%
2022-โ‚น56.12-76.64%
2021-โ‚น240.2068.45%
2020-โ‚น142.59-68.91%
2019-โ‚น458.62-57.11%
2018-โ‚น1,069-272.22%
2017โ‚น620.94-199.29%
2016-โ‚น625.35798.7%
2015-โ‚น69.58-128.31%
2014โ‚น245.80-204.62%
2013-โ‚น234.96602.7%
2012-โ‚น33.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น85.85-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.69-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA